双堆叠多叶准直器共面照射优化局部晚期肺癌左前降支剂量减免的可行性研究
所有计划均维持靶区覆盖和其他危及器官约束。
要点
- 所有生成计划均维持靶区覆盖和其他危及器官约束。
核心结论
- Ethos技术生成的计划较原始计划显著降低心脏和LAD剂量,且较常规加速器计划进一步降低心脏剂量,可能有助于减少心脏毒性。
主要发现
- 所有生成计划均维持最优靶区覆盖和其他危及器官约束。
临床怎么用
- 对于局部晚期肺癌根治性放疗患者,可考虑使用Ethos系统优化计划以降低心脏和LAD剂量,同时维持靶区覆盖和危及器官约束。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Recent studies have shown that cardiac substructures and particularly left anterior descending artery (LAD) dose strongly correlates with the incidence of late adverse cardiac events. We evaluated whether greater cardiac and, importantly, LAD dose sparing could be achieved using a newly introduced closed bore (O-ring gantry) linac with a double-stacked multileaf collimator (Varian Ethos) relative to conventional linacs. METHODS AND MATERIALS: Twenty patients with locally advanced non-small cell lung cancer previously treated with definitive chemoradiotherapy were retrospectively evaluated. Volumetric modulated arc therapy plans were retrospectively generated for the Ethos system using optimization criteria focused on reducing overall heart and LAD doses (Heart_Ethos). Plans were also reoptimized using the same optimization criteria on a conventional C-arm linac (Heart_TB). Investigational plans were compared with the original plans and with each other using standard dose-volume histogram metrics such as percentage (V) volume receiving a specific dose (x) in Gy (Vx) or mean dose (Dmean) in Gy. RESULTS: Statistically significant decreases existed between the Heart_Ethos and original plans for mean heart dose (11.3 vs 14.8 Gy; P < .001) and V5, V30, and V50 (63.6% vs 75.2%; P < .001, 7.1% vs 12.3%; P < .001, 2.1% vs 2.9%; P = .03, respectively) and also for LAD mean dose (4.8 Gy vs 12.0 Gy [P < .001]) and V15 (4.9% vs 21.5%; P < .001). Compared with Heart_TB, Heart_Ethos plans had significantly less mean heart dose (11.6 vs 12.2 Gy; P = .006), and less heart V5 (64.4% vs 67.2%; P = .049) and V30 (7.7% vs 8.8%; P = .03), whereas other parameters were not significant. Optimal target coverage and other organs at risk constraints were maintained for all generated plans. CONCLUSIONS: Heart_Ethos plans showed significant reduction in cardiac and LAD doses in comparison to the original plans while maintaining target and organ at risk goals. Our findings suggest that Ethos technology has the potential for better cardiac toxicity safety because Heart_Ethos plans were still able to reduce cardiac dose compared with Heart_TB plans.
引用
- Kim JP, Cunningham JM, Moats E, et al. Optimizing Dose Reduction to the Left Anterior Descending Artery in Patients With Locally Advanced Lung Cancer Treated With Definitive Radiation Therapy: A Feasibility Study of Coplanar Treatments Using Double-Stacked Multileaf Collimator. Adv Radiat Oncol. 2025. PMID: 40371385. doi:10.1016/j.adro.2025.101779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。